Supernus Pharmaceuticals
SUPN
#4517
Rank
C$2.40 B
Marketcap
$43.58
Share price
0.91%
Change (1 day)
14.32%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$0.48 B

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are C$0.48 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$0.47 B-57.35%
2022-12-31C$1.10 B0.22%
2021-12-31C$1.10 B14.15%
2020-12-31C$0.96 B32.22%
2019-12-31C$0.73 B2.29%
2018-12-31C$0.71 B262.72%
2017-12-31C$0.19 B24.66%
2016-12-31C$0.15 B13.31%
2015-12-31C$0.13 B25.38%
2014-12-31C$0.11 B35.11%
2013-12-31C$82.48 M127.24%
2012-12-31C$36.29 M-19.43%
2011-12-31C$45.04 M-50.72%
2010-12-31C$91.41 M0.84%
2009-12-31C$90.65 M-11.55%
2008-12-31C$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$1.39 B 186.29%๐Ÿ‡บ๐Ÿ‡ธ USA
C$78.99 B 16,150.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$105.22 B 21,546.88%๐Ÿ‡บ๐Ÿ‡ธ USA
C$45.38 B 9,235.75%๐Ÿ‡บ๐Ÿ‡ธ USA
C$148.59 B 30,468.54%๐Ÿ‡บ๐Ÿ‡ธ USA